Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BioNTech : Berenberg Bank Adjusts BioNTech PT to $400 From $235, Maintains Buy Rating

08/02/2021 | 10:48am EDT


© MT Newswires 2021
All news about BIONTECH SE
03:33pFDA ADVISORS VOTE AGAINST PFIZER-BIO : Bloomberg
MT
03:03pModerna Drops Ahead of FDA Committee COVID-19 Booster Decision
MT
02:54pPFIZER : US Reportedly to Buy More Doses of Pfizer-BioNTech COVID-19 Vaccine to ..
MT
12:43pUS TO BUY HUNDREDS OF MILLIONS MORE : Washington Post
MT
12:30pCDC CAUTIONS STATE HEALTH OFFICIALS : Washington Post
MT
11:17aEuropean ADRs Down Nearly 2% Friday as Mining, Steel Shares Drop
MT
07:00aMODERNA : U.S. COVID-19 booster debate moves to FDA vaccine advisory committee
RE
02:24aPFIZER : Hong Kong Assesses Pfizer-BioNTech's COVID-19 Jab In Booster Study
MT
09/16Pfizer-BioNTech, Moderna's Booster COVID-19 Shots Enters Real-Time Review in ..
MT
09/16UK Study to Mix Three COVID-19 Vaccine Doses in Adolescents
MT
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Financials
Sales 2021 16 863 M 19 775 M 19 775 M
Net income 2021 8 881 M 10 414 M 10 414 M
Net cash 2021 9 100 M 10 671 M 10 671 M
P/E ratio 2021 8,93x
Yield 2021 -
Capitalization 76 502 M 90 003 M 89 714 M
EV / Sales 2021 4,00x
EV / Sales 2022 3,25x
Nbr of Employees 2 500
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | BNTX | US09075V1026 | MarketScreener
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Last Close Price 316,75 €
Average target price 279,31 €
Spread / Average Target -11,8%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE357.13%90 003
GILEAD SCIENCES, INC.22.43%89 434
REGENERON PHARMACEUTICALS35.20%67 910
WUXI APPTEC CO., LTD.35.75%65 728
VERTEX PHARMACEUTICALS-20.83%48 539
BEIGENE, LTD.49.09%35 842